Bβ15-42 attenuates the effect of ischemia-reperfusion injury in renal transplantation

Journal of the American Society of Nephrology

Volumn 22, Issue 10, 2011, Pages 1887-1896

  Sörensen, Inga ^a   Rong, Song ^a   Susnik, Nathan ^a   Gueler, Faikah ^a   Shushakova, Nelli ^a   Albrecht, Melanie ^a   Dittrich, Anna Maria ^a   Von Vietinghoff, Sibylle ^a   Becker, Jan Ulrich ^a   Melk, Anette ^a   Bohlmann, Andrea ^a   Reingruber, Sonja ^b   Petzelbauer, Peter ^b,c   Haller, Hermann ^a   Schmitt, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Fibrex Medical Inc ^*  (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN; PROTEIN BBETA[15-42]; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPERFUSION INJURY; SURVIVAL; T LYMPHOCYTE ACTIVATION;

EID: 80053544083     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011010031     Document Type: Article

References (33)

1. Land WG: Innate immunity-mediated allograft rejection and strategies to prevent it. Transplant Proc 39: 667-672, 2007
2. Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D: Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 85: S3-S9, 2008 (Pubitemid 351522769)
3. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 364: 1814-1827, 2004 (Pubitemid 39488068)
4. Jang HR, Rabb H: The innate immune response in ischemic acute kidney injury. Clin Immunol 130: 41-50, 2009
5. Haller H, Dragun D, Miethke A, Park JK, Weis A, Lippoldt A, Gross V, Luft FC: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 50: 473-480, 1996 (Pubitemid 26274374)
6. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97: 1056-1063, 1996 (Pubitemid 26070586)
7. Goligorsky MS, Noiri E, Kessler H, Romanov V: Therapeutic effect of arginine-glycine-aspartic acid peptides in acute renal injury. Clin Exp Pharmacol Physiol 25: 276-279, 1998 (Pubitemid 28162296)
8. Friedewald JJ, Rabb H: Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491, 2004 (Pubitemid 38981983)
9. Jang HR, Ko GJ, Wasowska BA, Rabb H: The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med 87: 859-864, 2009
10. Harris ES, Nelson WJ: VE-cadherin: At the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 22: 651-658, 2010
11. Bach TL, Barsigian C, Yaen CH, Martinez J: Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. J Biol Chem 273: 30719-30728, 1998 (Pubitemid 28545554)
12. Gorlatov S, Medved L: Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: Mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Biochemistry 41: 4107-4116, 2002 (Pubitemid 34251050)
13. Zacharowski K, Zacharowski P, Reingruber S, Petzelbauer P: Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med 84: 469-477, 2006 (Pubitemid 43801325)
14. Groger M, Pasteiner W, Ignatyev G, Matt U, Knapp S, Atrasheuskaya A, Bukin E, Friedl P, Zinkl D, Hofer-Warbinek R, Zacharowski K, Petzelbauer P, Reingruber S: Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 4: e5391, 2009
15. Roesner JP, Petzelbauer P, Koch A, Mersmann J, Zacharowski PA, Boehm O, Reingruber S, Pasteiner W, Mascher D, Wolzt M, Barthuber C, Noldge-Schomburg GE, Scheeren TW, Zacharowski K: The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med 35: 1730-1735, 2007 (Pubitemid 46985877)
16. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, Castellino FJ, Groger M, Wolff K, Zacharowski K: The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11: 298-304, 2005 (Pubitemid 40460558)
17. Ahrens I, Peter K: FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. Curr Opin Investig Drugs 10: 997-1003, 2009
18. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Suselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT: Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53: 720-729, 2009
19. Wiedemann D, Schneeberger S, Friedl P, Zacharowski K, Wick N, Boesch F, Margreiter R, Laufer G, Petzelbauer P, Semsroth S: The fibrin-derived peptide Bbeta(15-42) significantly attenuates ischemia-reperfusion injury in a cardiac transplant model. Transplantation 89: 824-829, 2010
20. Gueler F, Rong S, Gwinner W, Mengel M, Brocker V, Schon S, Greten TF, Hawlisch H, Polakowski T, Schnatbaum K, Menne J, Haller H, Shushakova N: Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol 19: 2302-2312, 2008
21. Zacharowski K, Zacharowski PA, Friedl P, Mastan P, Koch A, Boehm O, Rother RP, Reingruber S, Henning R, Emeis JJ, Petzelbauer P: The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion. Shock 27: 631-637, 2007 (Pubitemid 46788162)
22. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237-244, 2002 (Pubitemid 34754067)
23. Halloran PF: T cell-mediated rejection of kidney transplants: A personal viewpoint. Am J Transplant 10: 1126-1134, 2010
24. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520, 2006
25. Anwar KN, Fazal F, Malik AB, Rahman A: RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J Immunol 173: 6965-6972, 2004 (Pubitemid 39541085)
26. Cernuda-Morollon E, Ridley AJ: Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res 98: 757-767, 2006
27. Li X, Hassoun HT, Santora R, Rabb H: Organ crosstalk: The role of the kidney. Curr Opin Crit Care 15: 481-487, 2009
28. Lu CY, Penfield JG, Kielar ML, Vazquez MA, Jeyarajah DR: Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 55: 2157-2168, 1999 (Pubitemid 29256471)
29. Schwarz A, Mengel M, Gwinner W, Radermacher J, Hiss M, Kreipe H, Haller H: Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 67: 341-348, 2005 (Pubitemid 40019257)
30. Shoskes DA, Halloran PF: Delayed graft function in renal transplantation: Etiology, management and long-term significance. J Urol 155: 1831-1840, 1996 (Pubitemid 26144066)
31. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schodel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU: Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci U S A 106: 21276-21281, 2009
32. Gueler F, Rong S, Mengel M, Park JK, Kiyan J, Kirsch T, Dumler I, Haller H, Shushakova N: Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection. J Immunol 181: 1179-1189, 2008
33. Schmitt R, Marlier A, Cantley LG: Zag expression during aging suppresses proliferation after kidney injury. J Am Soc Nephrol 19: 2375-2383, 2008